FDA Approved: DANZITEN — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA action on a supplemental application for DANZITEN (nilotinib) from Azurity Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• DANZITEN (NILOTINIB)

Snippet

SUPPL AP for DANZITEN (NILOTINIB)